We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -4.44% | 5.375 | 5.25 | 5.50 | 5.625 | 5.375 | 5.63 | 1,268,205 | 14:37:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.20 | 6.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/8/2020 16:58 | Totally correct !!! AVCT is a short not a long | amaretto1 | |
04/8/2020 16:13 | Losses.... Your own name on the stock market | ihavenoclue | |
04/8/2020 15:49 | You haven't a clue... your own words | losses | |
04/8/2020 14:44 | Losses 4 Aug '20 - 14:10 - 1611 of 1611 0 0 0 Invested both.. 'plonker' | ihavenoclue | |
04/8/2020 14:10 | Invested both.. | losses | |
04/8/2020 12:40 | nice post mate. Fascinating link with Beckman's already listed piece.....have people picked up on that yet? | qs99 | |
04/8/2020 12:31 | Make money on AVACTA. I bought this morning because they are using Saliva as testing now and should be immediate result. Genedrive has already completed initial evaluation of Beckman Coulter's RNA extraction chemistry to confirm compatibility with the Genedrive 96 SARS-CoV-2 test. Further work is ongoing to validate clinical saliva samples which are a very relevant sample type for applications such as high volume occupational screening. Beckman's RNAdvance Viral XP has already been listed as an extraction method for swab samples for use with the Centers for Disease Control's EUA-authorized COVID-19 test in FDA's FAQ on testing for SARS-CoV-2. Personally I think GeneDrive will get saliva test approved in 6 weeks time. We will see who is the winner ….. Genedrive ( £50m market cap ) vs Avacta. ( £322m ) I think Genedrive will come out on top.. | deanmatlazin | |
04/8/2020 12:26 | They arennt listed on the USA or am I missing something! | billthebank | |
04/8/2020 12:18 | market makers shaking this for stock they know this will shoot up this afternoon its not even started yet. | datait | |
04/8/2020 12:15 | Wait till the USA wakes up they will takes this over £1 for sure. | losses | |
04/8/2020 12:14 | will be £3 again soon dont worry | datait | |
04/8/2020 12:13 | Agreed 140p by the end of this week | inv | |
04/8/2020 12:12 | This company shafted shareholders with a placing at 80p when it was 250p. Price dropped for months. Good luck. | ostrading2 | |
04/8/2020 11:59 | cant buy any only sell market makers will take this up and let you buy at a price. Dont sell as you want get back cheaper. | datait | |
04/8/2020 11:54 | lets hope so the drift seems to have stopped at least! | qs99 | |
04/8/2020 11:52 | Back to 140 by end of week. | losses | |
04/8/2020 11:45 | Positive article: htxps://www.proactiv | pauliewonder | |
04/8/2020 11:35 | £3 again soon | datait | |
04/8/2020 11:34 | £1 looking like being breached shortly IMO DYOR and well done all those brave enough today! | qs99 | |
04/8/2020 11:24 | Enjoying the shake of weak holders......or those who came in again around the 70s and taken a quick %, but once out, this IMO should start trending higher as we await the 6 weeks they mention themselves as the deadline...>GLA and DYOR | qs99 | |
04/8/2020 11:10 | 110 here today :)) | g2theary | |
04/8/2020 10:27 | They still have been shafted. Todays deal is a start. They have lost massively in the testing market compared yo their peers. Way down the curve | phurley |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions